Response to "Railroading at the FDA"

Nat Biotechnol. 2017 Mar 7;35(3):207-209. doi: 10.1038/nbt.3819.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Letter
  • Comment